Cargando…

The Role of the CYP11B2 Promoter Polymorphism in the Diagnosis of Primary Aldosteronism

Background: nowadays, primary aldosteronism (PA) is suggested to be the most frequent cause of secondary hypertension and it reaches 10% of whole hypertensive population. The CYP11B2 promoter polymorphism might cause aldosterone overproduction. The aim of this study was to establish whether the poly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Żukowski, Łukasz, Wawrusiewicz-Kurylonek, Natalia, Szumowski, Piotr, Mojsak, Małgorzata, Abdelrazek, Saeid, Myśliwiec, Janusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290355/ https://www.ncbi.nlm.nih.gov/pubmed/32443509 http://dx.doi.org/10.3390/jcm9051519

Ejemplares similares

Pre-Processing Method for Contouring the Uptake Levels of [18F] FDG for Enhanced Specificity of PET Imaging of Solitary Hypermetabolic Pulmonary Nodules
por: Szumowski, Piotr, et al.
Publicado: (2021)

Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism
por: Sykała, Monika, et al.
Publicado: (2021)

Efficacy of (99m)Tc-DTPA SPECT/CT in diagnosing Orbitopathy in graves’ disease
por: Szumowski, Piotr, et al.
Publicado: (2019)

Enhancing the efficacy of (131)I therapy in non-toxic multinodular goitre with appropriate use of methimazole: an analysis of randomized controlled study
por: Szumowski, Piotr, et al.
Publicado: (2019)

Calculation of therapeutic activity of radioiodine in Graves’ disease by means of Marinelli’s formula, using technetium ((99m)Tc) scintigraphy
por: Szumowski, Piotr, et al.
Publicado: (2016)

Dosimetry during adjuvant (131)I therapy in patients with differentiated thyroid cancer-clinical implications
por: Szumowski, Piotr, et al.
Publicado: (2021)

Association of PTPN22 polymorphism and its correlation with Graves' disease susceptibility in Polish adult population—A preliminary study
por: Wawrusiewicz‐Kurylonek, Natalia, et al.
Publicado: (2019)

Application of 18F-PSMA-1007 PET/MR Imaging in Early Biochemical Recurrence of Prostate Cancer: Results of a Prospective Study of 60 Patients with Very Low PSA Levels ≤ 0.5 ng/mL
por: Mojsak, Małgorzata, et al.
Publicado: (2023)

HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes
por: Okruszko, Anna, et al.
Publicado: (2012)

Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development
por: Siewko, Katarzyna, et al.
Publicado: (2019)

Thyroid carcinoma with atypical metastasis to the pituitary gland and unexpected postmortal diagnosis
por: Popławska-Kita, Anna, et al.
Publicado: (2020)

SUN-711 Association of Single Nucleotide Polymorphisms of CYP11B2, CYP11B1 and CYP17A1 with Primary Aldosteronism in a Multi-Ethnic Malaysian Cohort
por: Azam, Afifah, et al.
Publicado: (2020)

Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1
por: Takeda, Yoshimichi, et al.
Publicado: (2023)

Exploration of KCNJ5 Somatic Mutation and CYP11B1/CYP11B2 Staining in Multiple Nodules in Primary Aldosteronism
por: Xie, Jing, et al.
Publicado: (2022)

Frequency of thrombophilia associated genes variants: population-based study
por: Wawrusiewicz-Kurylonek, Natalia, et al.
Publicado: (2020)

Proinflammatory Cytokines (IL-1, -6, -8, -15, -17, -18, -23, TNF-α) Single Nucleotide Polymorphisms in Rheumatoid Arthritis—A Literature Review
por: Koper-Lenkiewicz, Olga M., et al.
Publicado: (2022)

Pharmacogenomics, How to Deal with Different Types of Variants in Next Generation Sequencing Data in the Personalized Medicine Area
por: Tafazoli, Alireza, et al.
Publicado: (2020)

Analysis of Polymorphisms rs7093069-IL-2RA, rs7138803-FAIM2, and rs1748033-PADI4 in the Group of Adolescents With Autoimmune Thyroid Diseases
por: Sawicka, Beata, et al.
Publicado: (2020)

Immunohistochemical Analysis of CYP11B2, CYP11B1 and β-catenin Helps Subtyping and Relates With Clinical Characteristics of Unilateral Primary Aldosteronism
por: Sun, Luyan, et al.
Publicado: (2021)

LBODP025 A Novel Drug Discovery For Primary Aldosteronism Targeting Aldosterone Synthase (cyp11b2) And Kcnj5 Mutant
por: Otsubo, Yuri, et al.
Publicado: (2022)

Disturbances of Modulating Molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA Expressions in the Orbital Tissue from Patients with Severe Graves' Ophthalmopathy
por: Pawlowski, Przemyslaw, et al.
Publicado: (2015)

Association of Aldosterone Synthase Polymorphism (CYP11B2 -344T>C) and Genetic Ancestry with Atrial Fibrillation and Serum Aldosterone in African Americans with Heart Failure
por: Bress, Adam, et al.
Publicado: (2013)

Aldosterone Synthase Gene (CYP11B2) Polymorphism in Korean End-Stage Renal Disease Patients on Hemodialysis
por: Lee, Ji Eun, et al.
Publicado: (2009)

Association of aldosterone synthase (CYP11B2) -344 T/C polymorphism with diabetic nephropathy: A meta-analysis
por: Xu, Haiyan, et al.
Publicado: (2016)

Assessment of different markers of ovarian reserve in women with papillary thyroid cancer treated with radioactive iodine
por: Adamska, Agnieszka, et al.
Publicado: (2021)

High glucose stimulates expression of aldosterone synthase (CYP11B2) and secretion of aldosterone in human adrenal cells
por: Shimada, Hiroki, et al.
Publicado: (2017)

The FOXP3 rs3761547 Gene Polymorphism in Multiple Sclerosis as a Male-Specific Risk Factor
por: Wawrusiewicz-Kurylonek, Natalia, et al.
Publicado: (2018)

Genetic Analyses of the Chimeric CYP11B1/CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism
por: Lee, Ihn Suk, et al.
Publicado: (2010)

Pharmacogenomic Biomarkers of Follicle-Stimulating Hormone Receptor Malfunction in Females with Impaired Ovarian Response—A Genetic Survey
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Association of −344C/T polymorphism in the aldosterone synthase (CYP11B2) gene with cardiac and cerebrovascular events in Chinese patients with hypertension
por: Wang, Lili, et al.
Publicado: (2020)

Association between Aldosterone Synthase (CYP11B2) Gene Polymorphism and Hypertension in Pashtun Ethnic Population of Khyber Pakhtunkwha, Pakistan
por: Shah, Waheed Ali, et al.
Publicado: (2023)

Diagnosis and management of primary aldosteronism
por: Vilela, Leticia A. P., et al.
Publicado: (2022)

A Proliferation-Inducing Ligand Regulation in Polymorphonuclear Neutrophils by Panax ginseng
por: Ratajczak-Wrona, Wioletta, et al.
Publicado: (2020)

The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model
por: Wielgat, Przemyslaw, et al.
Publicado: (2021)

Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry
por: Stenman, Adam, et al.
Publicado: (2019)

Effects of ACTH, dexamethasone, and adrenalectomy on 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat central nervous system
por: Ye, Ping, et al.
Publicado: (2008)

The impact of specific pulmonary arterial hypertension therapy on cardiac fluorodeoxyglucose distribution in PET/MRI hybrid imaging–follow-up study
por: Kazimierczyk, Remigiusz, et al.
Publicado: (2023)

Nuclear imaging in the diagnosis of primary aldosteronism
por: Powlson, Andrew S., et al.
Publicado: (2015)

New advances in the diagnosis of primary aldosteronism
por: Shen, Hang, et al.
Publicado: (2020)

Testing the Utility of Polygenic Risk Scores for Type 2 Diabetes and Obesity in Predicting Metabolic Changes in a Prediabetic Population: An Observational Study
por: Padilla-Martinez, Felipe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tda22p2tssmnhuq8gfptjc39n5